Steven Capuano: A Rehabilitation Product Is Either a Wellness Tool or a Medical Device, and Founders Keep Deciding by Accident

The classification is a design decision, a marketing decision, and a liability decision at the same time. Steven Capuano argues that small product founders in the rehabilitation category make it without realizing they are making it, and the accident is the expensive part.

Steven Capuano has a question he asks founders who tell him they are building a recovery or rehabilitation product. He does not ask what the product does. He asks what they intend to say it does. The two questions sound the same, and the gap between them is where a small product company quietly decides whether it is building a general wellness tool or a regulated medical device.

Most founders, in his experience, have not registered that the question has two answers. They have a physical object in mind, a clear sense of who it helps, and a folder of language describing the relief it provides. What they do not have is an awareness that the language, not the object, is what determines which regulatory world the product lives in. By the time that becomes clear, the marketing copy has been written, the packaging has been printed, and the positioning has been set.

The Claim Is the Classification

Capuano launched SpinalTechUSA in 2026 with four patented products in the wellness and rehabilitation tools category, and he spent meaningful time on the classification question before the design was finished. His framing is that a product does not become a medical device because of what it is made of or how sophisticated it is. It becomes a medical device, in regulatory terms, largely because of the claims attached to it about what it treats, diagnoses, or mitigates.

That distinction matters more in rehabilitation than in almost any other consumer category, because rehabilitation language naturally drifts toward the clinical. A founder describing a recovery tool wants to say it relieves a condition, supports healing, or corrects a problem. Each of those phrases moves the product closer to the line, and a founder writing marketing copy is rarely thinking about the line at all.

The Wellness Lane Is Wider Than Founders Think

The first thing Capuano tells founders is that the general wellness lane is broad and legitimate, and that most of them belong in it. A product positioned around general wellbeing, comfort, relaxation, mobility, or supporting a healthy lifestyle can occupy that space honestly, without claiming to treat or cure anything. For a small founder, that lane is not a consolation prize. It is the commercially sensible place to be, because it keeps the product out of a regulatory process that small companies are rarely funded to complete.

The mistake is not choosing the wellness lane. The mistake is choosing it implicitly while writing copy that quietly steps out of it. A founder who has decided, in practice, to sell a general wellness product, and who then describes it as something that resolves a specific medical condition, has the worst of both arrangements. The product carries the obligations of a medical claim without the substantiation, the testing, or the regulatory clearance that a medical claim is supposed to rest on.

“The product does not become a device because of what it is. It becomes a device because of what you say about it.”

The Sentence That Moves a Product Across the Line

Capuano describes the crossing point in concrete terms. It is usually a single sentence, and the sentence usually appears on a website, a product insert, or an advertisement rather than in any document the founder thinks of as legally significant. The sentence claims that the product treats a named condition, corrects a diagnosed problem, or produces a clinical outcome. The founder writes it because it is the most persuasive thing they can say. It is also the thing that reclassifies the product.

His advice is not that founders should write timid copy. It is that they should decide, deliberately and early, which set of claims they are entitled to make, and then write the strongest possible copy inside that set. A wellness product described with discipline can be marketed aggressively and honestly. The failure mode is the founder who reaches for a clinical claim because it converts better, without registering that the claim has moved the entire product into a category it was never built to satisfy.

The Cost Lives in Three Places

When a product ends up across the line by accident, Capuano sees the cost surface in three places. The first is liability. A medical claim that the product cannot substantiate is exposure, and a small company is the least equipped party in the chain to absorb a claim that the product failed to do what its own copy promised.

The second is the channel. Serious distributors and retail buyers in the rehabilitation space have seen this pattern before, and their legal and compliance teams read product claims closely. A founder who shows up with clinical language and no clearance to support it is not a sophisticated partner. They are a risk the buyer now has to price in, and the conversation gets harder rather than easier.

The third is the rebuild. Correcting the problem after launch means rewriting the website, reprinting the packaging, retraining whoever sells the product, and explaining the change to anyone who already bought into the original positioning. The same decision made before design would have cost nothing. Made after launch, it costs the founder the one thing a small company cannot easily recover, which is time in the market with a consistent message.

The Clinician Founder Faces the Strongest Version of the Temptation

Capuano is candid that his own background makes the trap more tempting, not less. As a chiropractor, his instinct is to describe what a product does in clinical terms, because that is the language he has used with patients for years. A practitioner founder knows exactly how to make a therapeutic claim sound credible, which is precisely why a practitioner founder has to be the most disciplined about not making one without the substantiation to back it.

He treats his clinical credibility as something to protect rather than spend. The fastest way to undermine it, in his view, is to attach his professional authority to a product claim that the product cannot support under scrutiny. The slower and more durable path is to let the clinical background inform how the product is designed and who it is built for, while keeping the public claims squarely inside what the wellness positioning allows.

The Decision Belongs at the Design Stage

The reason Capuano pushes the classification question to the front of the process is that it is cheap to answer early and expensive to answer late. A founder who decides the lane before the product is designed can build the design, the testing, the copy, and the channel strategy around a single consistent answer. A founder who discovers the question after launch is unwinding decisions that have already hardened into packaging, contracts, and customer expectations.

He is also clear about the limits of his own framing. The classification question, in any specific case, is one for qualified regulatory counsel, not for a founder reasoning by analogy or for a chiropractor turned product builder offering a general operating view. What he offers founders is not the legal answer. It is the insistence that the question exists, that it is a binary, and that they are answering it whether they realize it or not.

Steven Capuano is the founder of SpinalTechUSA, a product company built around four patented wellness and rehabilitation innovations launched in 2026. More at spinaltechusa.com and stevencapuano.com.